In this video we discuss promising results of the anti–PD-L1 agent avelumab in patients with metastatic Merkel cell carcinoma who had previously been treated with chemotherapy.
Howard L. Kaufman, MD
Advertisement
Articles by Howard L. Kaufman, MD
Advertisement
Latest Updated Articles
Avelumab Produces Durable Responses in Metastatic Merkel Cell CarcinomaPublished: June 22nd 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
More Global Expertise and Talent Are Needed to Administer Cell Therapies
4
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
5
